Your browser doesn't support javascript.
loading
FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9/CYLD/NF-κB axis.
Chen, Zhengxin; Wang, Shuai; Li, Hai-Lin; Luo, Hui; Wu, Xiaoting; Lu, Jiacheng; Wang, Hong-Wei; Chen, Yuanyuan; Chen, Dan; Wu, Wen-Ting; Zhang, Shuyu; He, Qiongqiong; Lu, Daru; Liu, Ning; You, Yongping; Wu, Wei; Wang, Huibo.
Afiliação
  • Chen Z; Department of Neurosurgery, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China; Institute for Brain Tumors, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical U
  • Wang S; Department of Hematology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Li HL; Department of Neurosurgery, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Luo H; Department of Neurosurgery, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Wu X; Department of Intensive Care Unit, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China.
  • Lu J; Department of Neurosurgery, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Wang HW; Department of Neurosurgery, Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
  • Chen Y; Division of Molecular Thoracic Oncology, German Cancer Research Center, 69120 Heidelberg, Germany.
  • Chen D; Ministry of Education and Shanghai Key Laboratory of Children's Environmental Health, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
  • Wu WT; Beyster Center for Genomics of Psychiatric Diseases, Department of Psychiatry, University of California San Diego, La Jolla, CA 92093, USA.
  • Zhang S; State Key Lab of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, Jiangsu 215123, China.
  • He Q; Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Lu D; State Key Laboratory of Genetic Engineering and MOE Key Laboratory of Contemporary Anthropology, Collaborative Innovation Center for Genetics and Development, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai 200433, China.
  • Liu N; Department of Neurosurgery, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • You Y; Department of Neurosurgery, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China; Institute for Brain Tumors, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical U
  • Wu W; Department of Neurosurgery, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China. Electronic address: weiwu1974@126.com.
  • Wang H; Department of Neurosurgery, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China; Institute for Brain Tumors, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical U
Mol Ther ; 30(7): 2568-2583, 2022 07 06.
Article em En | MEDLINE | ID: mdl-35351656
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Proteínas Proto-Oncogênicas c-fos / Glioblastoma / Células-Tronco Mesenquimais Limite: Humans Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Proteínas Proto-Oncogênicas c-fos / Glioblastoma / Células-Tronco Mesenquimais Limite: Humans Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article